Rx PharmFilm® Approvals
Rx Market Opportunity
Development Pipeline
Partnered Products
Rx PharmFilm® Approvals
Two prescription products, utilizing MonoSol Rx’s PharmFilm® Technology, have received FDA approval in 2010. MonoSol Rx developed both formulations and the products are commercially manufactured in our state-of-the-art production facility located in Portage, Indiana. These Rx products will be marketed by our commercial partners.
- Zuplenz
(Ondansetron)
- Treatment of Nausea
& Vomiting
- July, 2010
- Strativa Pharmaceuticals
- Suboxone (Buprenorphine/
Naloxone)
- Treatment of Opioid Dependence
- August, 2010
- Reckitt Benckiser